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Abstract In Japan, overweight/obesity in adults defined as
a body mass index of 25 kg/m2 or over has roughly doubled
among middle-aged men over the past few decades. In
parallel with a population rightward shift in the degree of
obesity, the proportion of hypertension attributed to
overweight has increased. There is an indication that the
incidence of ischemic stroke and coronary heart disease
remains stable or has been increasing among men. These
facts indicate that the relative importance of cardiovascular
diseases (CVD) risk factors may have changed. Although it
was confirmed at an individual level that the degree of
obesity was positively associated with CVD incidence,
there is a sizeable proportion of individuals who are at an
increased CVD risk state without being overweight/obese
in today’s Japan. Thus, further implementation and promo-
tion of activities are needed to bring about meaningful
changes in the obesity trend in communities that are
harmonized with other domains of CVD prevention
activities.
Keywords Cardiovascular disease . Obesity .
Hypertension . Japan . Epidemiology . Prevention
Introduction
Stroke mortality had been much higher in Japan compared
with other industrialized populations until it declined
steeply between 1965 and 1990 due mainly to a decrease
in the level of blood pressure [1], and by improvement in
nutritional status [2]. At the same time, coronary heart
disease (CHD) mortality remains as low as one-third to
one-fifth of that in the United States [3] even with the
westernization of lifestyles that has brought about increases
in blood cholesterol levels and the degree of obesity.
However, there are some indications that the decline of
stroke incidence decelerated or stopped [4, 5], and CHD
incidence increased [6, 7]. In this review, we first describe
the population trend in the degree of obesity as measured
by the body mass index (BMI), and review prospective
cohort studies that reported associations of obesity meas-
ures and metabolic syndrome (MetS) with cardiovascular
diseases (CVD) in Japanese. We then review literature that
reported secular and geographical trends in the incidence of
CVD subtypes, including ischemic stroke subtypes and
percutaneous coronary intervention (PCI) to help our
understanding of shifts of CVD risk factors and their
determinants, including obesity.
Predictive diagnostics, targeted preventive measures and
personalized medicine (PPPM) is a new paradigm proposed
by the European Association for Predictive, Preventive and
Personalised Medicine [8]. For the primary prevention of
CVD, population-based prevention aligned with identifica-
tion of and intervention to high-risk individuals who have
high estimated CVD risk, are essential. In order to enable
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these activities, cycles of research, formation and imple-
mentation of guideline and regulation, and evaluation are
necessary. To efficiently and effectively facilitate this
process, communication among medical and public health
professionals is especially important [9].
From a PPPM perspective, we derive conclusions that
implementation and promotion of activities for bringing
about meaningful changes in the obesity trend are essential.
However, this effort should be harmonized with other
domains of CVD prevention activities, such as measures
against smoking and salt intake.
Obesity trend in Japan
In Japan, obesity in adults defined as a BMI of 30 kg/m2 or
over [10] has roughly doubled over the past few decades in
men, although the absolute prevalence is only 3% [11] in
contrast to much higher prevalence in OECD countries (16%,
average) [12] or in the United States (34%) [13]. If obesity is
defined by a BMI greater than or equal to 25 kg/m2 (Japanese
criterion) [14], 28.6% of men and 20.6% of women were
obese in 2008. The average BMIs have been increasing
consistently since 1950 except for younger women [11, 15]
(Figs. 1, 2). Namely, the average BMI of women aged 30–39
and that of women aged 40–49 have been decreasing from
1975 to 1985, respectively. However, if aging-related changes
of BMI by birth cohorts are compared, aging during middle
age seems to be related to weight gain on average even in
younger generation women (born in 1960’s), who weighed
less than the older generation at a younger age (30–39), but
gained thereafter at least through their sixties (Figs. 3, 4). It is
noteworthy that younger generation men enter middle age
with a higher BMI, and they experience a continuous increase
of BMI. These observations are partly supported by a
longitudinal analysis of repeatedly-measured body weight
among the same individuals [16].
Urban and rural difference of obesity trend
It was reported that the mean BMI of men in an urban
community has increased from 22.5 kg/m2 in the earliest
survey (1963–1966) to 23.8 kg/m2 in the last survey (2000–
2003) [7] (Table 1). The mean BMI of women in an urban
community, however, decreased from 23.4 to 22.8 kg/m2
during the same period. Contrarily, the mean BMI increased
in both men and women in a rural community (22.6 to
24.0 kg/m2 in men and 23.1 to 24.3 kg/m2 in women). In the
Hisayama Study of a suburban community, the mean BMI
also increased from 21.3 kg/m2 in 1961 to 23.5 kg/m2 in
2002 in men and from 21.7 to 22.9 kg/m2 in women [17]. A
national survey also found that prevalence of overweight
(BMI ≥25 kg/m2) among men increased regardless of the
residential areas, whereas that among women aged 50 or
over in urban areas has also been decreasing [18].
Association of degree of obesity with blood pressure
In the same studies that reported secular BMI changes in rural/
suburban and urban men and women, mean blood pressure
(BP) changes were also described [7, 17]. Although systolic
BP decreased in both men and women from either rural/
suburban or urban communities, the magnitude of the
decrease was more prominent in rural/suburban men and
women and in urban women than in urban men. Further,
diastolic BP increased in urban men. These observations
imply the existence of two sets of factors with opposite
directions; one characteristic of previous rural areas and the
other more typical of recent urban areas, especially, men.
Indeed, hypertension without being overweight used to
Fig. 1 Secular changes in the mean body mass index in Japanese
men, National Health and Nutritional Survey in Japan 1950–2006
Fig. 2 Secular changes in the mean body mass index in Japanese
women, National Health and Nutritional Survey in Japan 1950–2006
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constitute a majority of the hypertension cases in rural
communities in 1960’s, but it decreased significantly by the
1980’s [19]. This change was accompanied by increases in
overweight and also in the proportion of hypertension
among the overweight. Furthermore, a correlation between
BMI and diastolic BP was not present in the 1960’s in rural
men aged 40 to 49; however, it emerged in the 1970’s and
became stronger in the 1980’s. In contrast, the prevalence of
hypertension in urban men has been increasing since the
1990’s [20]. This is partly due to a continuous increase in the
prevalence of overweight, but the authors have suggested
other factors besides obesity such as mental stress, increased
workload and sleep deprivation since the increase has also
been observed in individuals without overweight.
Although further nationwide studies are warranted,
hypertension attributed to overweight/obesity is increasing
in Japan. Prospective studies have also confirmed the
associations [21–23]. Since it was reported that the
strongest risk factor for the development of hypertension
was a higher BMI, and that 40% of new hypertension cases
was attributed to overweight/obese in US women with 66%
of women being overweight/obesity [24], it would be
reasonable to take measures against overweight/obesity as
one way to prevent hypertension in Japan as well.
Stroke and ischemic stroke subtypes
Ischemic stroke consists of three major subtypes with
different etiologies: lacunar, nonlacunar thrombotic (athero-
thrombotic), and cardioembolic. The underlying vascular or
non-vascular pathophysiologies of each subtype differ, such
as lipohyalinosis and microatheroma for lacunar stroke, or
atherosclerosis for atherothrombotic stroke. Intracerebral
hemorrhage (ICH) is also characterized by lipohyalinosis
[25]. Lipohyalinosis is arteriosclerosis of the arteriole, and
characterized by degeneration of the media of small arteries
with replacement of vascular muscle by lipid deposits and
collagen (sclerosis) and loss of structural integrity of the
vessel wall [26]. Therefore, risk factors for lacunar stroke
and ICH overlap, among which hypertension is the most
important [27]. The rapid decrease of stroke mortality in
Japan since 1965 can be attributed to the decrease in ICH
[5], which is due to improvement in hypertension control,
the downward shift of population blood pressure distribu-
tion and also to improvement in nutritional status man-
ifested as an increase in blood cholesterol level [28]. It was
also hypothesized that ischemic stroke subtypes may be
shifting from lacunar to atherothrombotic stroke predomi-
nance [4, 17], as observed in Western populations [29]. In
the Hisayama Study, there was a relative increase of
atherothrombotic infarction (22% to 32%) and decrease of
lacunar infarction (65% to 41%) in men, although the
overall stroke incidence rate decreased from 8.7 in men and
4.3 in women per 1,000 person-years in the first cohort
(1961–1973) to 3.9 in men and 2.6 in women in the third
cohort (1988–2001) [17]. The proportion of lacunar stroke
in an urban community was similar [30] to that in the
Hisayama Study (50% to 60% in both men and women),
but this study did not find a similar secular trend.
These rapid (about 30-year) trends indicate changes in
environment and behavioral factors that would have
brought shifts in the risk factors [19]. As stated earlier,
overweight/obesity is attributed more to the development of
hypertension [19, 20, 31]. Overweight/obesity has other
metabolic impacts such as diabetes. Since diabetes is a
significant risk factor for all the ischemic stroke subtypes
[29], the current overweight/obesity trend may increase the
relative importance of diabetes and other metabolic dis-
orders in the development of stroke and its subtypes in the
Japanese population [32, 33].
Fig. 4 Changes in the mean body mass index with age by birth cohort
of Japanese women, National Health and Nutritional Survey in Japan
1950–2005
Fig. 3 Changes in the mean body mass index with age by birth cohort
of Japanese men, National Health and Nutritional Survey in Japan
1950–2005
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Associations of obesity measures with ischemic stroke
Findings on the associations of obesity measures with
ischemic stroke from individual cohort studies may seem
inconsistent (Table 2) with null [34–36], positive associa-
tion only in women [37–40], and positive association only
in men [41]. The reasons for the inconsistency are not clear
due to differences in sample sizes, obesity measures and the
references used, or covariates in the statistical models;
however, baseline years of the studies with null findings are
generally old (1960’s to 1970’s). Recently, a pooling project
reported a meta-analysis finding based on individual
participant data from 16 existing high-quality prospective
cohort studies in Japan comprising both rural and urban
areas [42]. In this prospective study with 1,113 incident
strokes, hazard ratios (HRs) for total stroke, cerebral
infarction, and ICH of men with BMI 27.0 kg/m2 or greater
were 1.80 (95% confidence interval: 1.31–2.47), 1.86
(1.28–2.69), and 2.19 (1.10–4.38) compared to those with
BMI less than 21.0 kg/m2. The respective values in women
were 1.64 (1.24–2.16), 1.68 (1.16–2.43), and 1.75 (1.01–
3.05). These associations, especially of ICH, were found to
be mediated by systolic BP. Thus, it is plausible that BMI is
positively associated with cerebral hemorrhage and infarc-
tion, and that overweight/obesity increases stroke risk
partly through the elevation of BP. Yet, it is still unknown
why earlier studies did not find a significant association
between BMI and stroke incidence. Recently, the popula-
tion attributable fraction (PAF) of normal and higher BP in
reference to optimal BP (systolic BP <120 mmHg and
diastolic BP <80 mmHg) for stroke incidence [43] were
reported to have decreased from the earliest cohort initiated
in the 1960’s to the latest cohort started in the 1980’s, and
which were considered to suggest an increase in the
contribution of other, possibly obesity-related, factors
[44]. Indeed, PAF of obesity to cerebral infarction increased
gradually from 6% in the first cohort to 9% in the third
cohort in the Hisayama Study, although the statistical
significance of the difference was not indicated in this
study [17]. Since obesity is associated with a wide range of
CVD risk factors, positive associations between obesity
measures and each ischemic stroke subtype were also
reported from the Atherosclerosis Risk in the Communities
Study consisting of African-Americans and Caucasians in
four US communities [45]. Collectively, avoidance of
obesity offers the potential of reducing stroke in Japan.
Increasing trend of CHD in middle-aged urban men
In the Akita-Osaka Study, clinical data on PCI have also been
collected since 1980, and a significant increase in the
incidence of CHD was observed between the periods 1980
to 1987 and 1996 to 2004 among urban (Osaka) middle-aged
Table 1 Trends in age-adjusted mean body mass index and systolic blood pressure in the Hisayama and the Akita-Osaka Studies
Men Women
1960’s 1970’s 1980’s 1990’s 2000’s 1960’s 1970’s 1980’s 1990’s 2000’s
Body mass index (kg/m2)
Hisayamaa 21.3 21.7 22.8 NA 23.5 21.7 22.5 22.9 NA 22.9
Akitab 22.6 23.1 22.9 23.2 24.0 23.1 24.0 23.9 23.9 24.3
Osakab 22.5 22.3 22.7 23.3 23.8 23.4 22.9 22.6 22.9 22.8
Systolic blood pressure (mmHg)
Hisayamaa 162 157 151 NA 148 163 161 154 NA 149
Akitab 150 141 136 133 132 142 135 132 129 129
Osakab 135 135 132 131 132 135 130 130 129 128
Diastolic blood pressure (mmHg)
Hisayamaa 91 90 87 NA 89 88 87 83 NA 86
Akitab 87 86 85 83 86 83 81 80 79 81
Osakab 80 81 80 84 85 80 79 78 80 80
a Data for Hisayama was from Kubo et al. [17]
b Data for Akita and Osaka were from Kitamura et al. [7]
NA indicates not available.
Mean values of the Hisayama Study were among hypertensive subjects (systolic blood pressure ≥140 mmHg or diastolic blood pressure
≥90 mmHg, or current use of antihypertensive agents)
Measurements were carried out in 1961, 1974, 1988, and 2002 in the Hisayama Study, and in periods 1964–66, 1976–79, 1984–87, 1992–95, and
2000–03 in the Akita-Osaka Study
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men [7]. Age-adjusted incidence of myocardial infarction
increased from 45 per 100,000 person-years in the 1960’s to
90 in the last survey period between 1996 and 2003. CHD
including PCI increased from 56 per 100,000 person-years in
the 1980’s to 127 in the aforementioned last survey period.
A previous autopsy study revealed that the pathology of
myocardial infarction among urban men included a larger
infarction associated with hypercholesterolemia-derived
atherosclerosis of the coronary arteries as observed in
Western populations compared to that found in rural men,
which was smaller and disseminated infarction associated
with hypertension-derived atherosclerosis of coronary
arteries [46]. Therefore, the increase of CHD among
middle-aged urban men from the 1980s could be due to a
concurrent increase in mean total cholesterol level and BMI.
AMI incidence rates in rural/suburban men were also
reported to have increased in the Takashima AMI registry
from 66.5 per 100,000 person-years in 1990–92 to 100.7 in
1999 to 2001 [47]. In the Hisayama Study, however, CHD
incidence was shown to be constant from the first to the third
cohort for both men and women [48], except in men aged 80
or over who experienced a linear increase (statistical
significance of the trend was not indicated in this study).
Associations of obesity measures with CHD
Due to the small number of incidents in women, most
previous studies in Japan did not find an association of the
degree of obesity with the CHD incidence inwomen (Table 2).
In the Ni-Hon-San Study, relative weight was not associated
with CHD; however, the number of CHD cases was very
small (n=22 in Japan) [49]. Later studies generally found
positive associations between BMI and CHD in men. BMI
was positively associated with CHD in the Honolulu Heart
Program [36]. BMI ≥25 kg/m2 was associated with an
increased incidence of ischemic heart disease in men in the
CIRCS Study [39]. BMI ≥30 kg/m2 was associated with an
increased incidence of CHD compared to those with BMI
23.0–24.9 kg/m2 in the JPHC Study [23]. In the aforemen-
tioned pooling project of existing cohort studies, the
association in men was confirmed: compared to those with
a BMI of less than 21.0 kg/m2, HR for MI of men with a
BMI of 27.0 or greater was 2.84 (1.52–5.29) and that of
women was 1.13 (0.47–2.74) [42]. Further, adjustment for
total cholesterol, systolic BP, high-density lipoprotein cho-
lesterol, and diabetes, possible mediators, did not totally
explain the association between BMI and myocardial
infarction. The authors suggested the existence of other
unmeasured factors that mediate the association, such as
prothrombotic factors or low-grade systematic inflammation,
and implied that avoidance of obesity offers the potential of
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Risks related to metabolic syndrome and its screening
Metabolic syndrome (MetS) is a cluster of risk factors for
CVD and type 2 diabetes mellitus, which occur together
more often than by chance alone [50].
Although various diagnostic criteria have been proposed
by different organizations [50], the risk factors included are
generally common: raised blood pressure, dyslipidemia
(raised triglycerides and lowered high-density lipoprotein
cholesterol), raised fasting glucose, and abdominal obesity.
While the criteria proposed by the International Diabetes
Federation (IDF) as well as the fact that Japanese made
abdominal obesity an obligatory component [51] (Table 3),
the criteria of the American Heart Association/National
Heart, Lung, and Blood Institute (AHA/NHLBI) do not
mandate abdominal obesity as a required risk factor; three
abnormal findings out of five will qualify a person for the
MetS.
The goal of population-based screening of MetS would
be to identify a risk state for the development of CVD and
diabetes in order to intervene. To maximize public health,
the tool used must not overlook a substantial proportion of
high-risk individuals, who eventually develop the condi-
tions. In a European population-based study, non-obese
people with two or more IDF MetS factors were less
prevalent than IDF MetS individuals, but their CVD
mortality rate was comparable to that of individuals with
IDF MetS [52]. The PAF calculated from the data was
10.0% for men with two or more risk factors without
abdominal obesity and 28.2% for men that met IDF MetS
criteria. This suggests that IDF criteria would miss at least
an opportunity to provide interventions to such individuals.
In Japan, there were reportedly more non-overweight
individuals with a constellation of risk factors than
overweight individuals with the same constellation (i.e.,
IDF MetS equivalent) in the general population, with both
groups having a similar mortality risk [53]. Hence, the PAF
was reported to be greater in non-overweight individuals
with two or more risk factors (9.4%) than in overweight
individuals with the same number of risk factors (7.8%). As
similar findings were repeatedly reported [54–58], there has
been concern regarding the appropriateness of the public
health screening that currently excludes such individuals
from the diagnosis of MetS in Japan. Therefore, at the
screening level, focusing only on the abdominal obesity-
prerequisite IDF MetS cannot be recommended in current
Japan where a large proportion of individuals are in a risk
state for CVD without being overweight. Nevertheless, IDF
MetS is easy to understand pathophysiologically, and
interventions targeting abdominal obesity have proved to
be effective [59]. The reason is yet unclear for the high
prevalence of a risk factor constellation without being
overweight in Japan. How to effectively intervene in such
cases must also be investigated.
Concluding remarks and outlook
Obesity is a major health concern for most of the world
given its already high prevalence. Obesity prevalence has
doubled or tripled in many countries since 1980, and is still
projected to increase. Even though various measures and
actions have been undertaken to avoid fulfillment of this
projection, it is almost certain that an obesity epidemic
persists. This epidemic seems to have been affecting some
age-, sex-, and area-subgroups of the population dispropor-
tionately. However, overall and recent trends do not seem to
differ considerably.
Even in a relatively lean population like the Japanese, an
association has been established between adiposity and
CVD risk factors, including hypertension, diabetes mellitus,
and dyslipidemia. Thus, the notion that obesity confers
increased CVD risk seems plausible. However, there is a
sizeable proportion of individuals who are at an increased
CVD risk state without being currently overweight/obese.
Public health activities to prevent CVD and promote
population health should not overlook this fact.
Although a current public health screening and inter-
vention program in Japan that started in 2008 has
considerably raised public awareness of obesity and
metabolic syndrome, it overemphasized measures to deal
with abdominal obesity to the detriment of predictive
diagnosis and targeted prevention. Consequently, the
intervention program has tended to overlook the opportu-
nity to intervene with non-obese high risk individuals, such
as lean hypertensives. More extensive communication is
Table 3 Components of metabolic syndrome in Japan [51]
Abdominal obesity (obligatory component) ≥85 cm in men and ≥90 cm in women
Raised blood pressure Systolic blood pressure ≥130 mmHg or
Diastolic blood pressure ≥85 mmHg
Dyslipidemia Triglycerides ≥150 mg/dl or
High-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women
Raised fasting glucose Fasting glucose ≥100 mg/dl
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necessary among medical and public health professionals as
well as health and insurance administrators to amend the act
for this program [60]. We conclude that further implemen-
tation and promotion of activities to bring about meaningful
changes in the obesity trend in rural and urban communities
are needed. However, such activities should be harmonized
with other domains of CVD prevention activities.
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